17th Eemeli Workshop. Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo. Juhani Luotola, Orion Diagnostica Oy

Size: px
Start display at page:

Download "17th Eemeli Workshop. Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo. Juhani Luotola, Orion Diagnostica Oy"

Transcription

1 17th Eemeli Workshop Wednesday 13th August 2014 VTT, Micronova, Tietotie 3, Espoo Juhani Luotola, Orion Diagnostica Oy Juhani Luotola / R&D 13/12/2014 1

2 2

3 Personalized Diagnostics and Care Personalized health care is a global trend, which creates plenty of new business opportunities An individualized health care is needed, so that eg. the most expensive treatments can be targeted to those who really will benefit from these treatments. The public sector has the main responsibility for the reforms, but this goal is realized only in broad cooperation with all sectors. This program allows the Finnish actors to be involved at the forefront in developing new operating models. Finnish health care infrastructure provides a good framework for the implementation of the program and for new ways of acting. The program is an excellent example of cooperation between different sectors of the society! 3

4 Personalized Diagnostics and Care The overall objective of the Personalized Diagnostics and Care program is to partially change health care priorities from waiting of symptoms towards early prevention of disease using personalized diagnostics and treatment. The program will also create new health care technologies and practices. Performing the research needed in the program would be completely impossible without the cooperation with major actors in the health sector. Extensive co-operation with all parties enables utilization of the genome information in clinical healthcare by an effective and responsible manner, taking also into account the sociological and socioeconomic aspects. The Academy of Finland program Personalised Health From genes to society is also complementing the whole. 4

5 For the first time in Finnish health and well-being area, "Personalized Diagnostics and Care" program will enable stakeholders in public and private health care, occupational health, multidisciplinary research and industry to build together new approaches for personalized diagnostics and care. GET IT DONE. Personalized Diagnostics and Care The overall objective of the program is to enhance the use of personalized medicine, especially personalized diagnostics and treatments. The program focuses on the efficient utilization of personal health records, patient records and genomic information including new technologies in point-of-care testing. The ICT solutions to be developed, including genetic and other laboratory data, support the effective use of patient data both in the prevention and care of diseases. - GET IT DONE. 5

6 The Consortium The consortium consists of 17 parties, 12 companies and 5 research organisations with 16 research groups in total. The participating companies: Labsystems Diagnostics Oy (earlier Ani Labsystems ALS), ArcDia International Oy Ltd, Carea Kymenlaakso Social and Health Services, Duodecim Medical Publications Ltd, Pharmaceutical Information Centre (LTK), HUS - The Hospital District of Helsinki and Uusimaa, Oy Medix Biochemica Ab, Mehiläinen Oy, Orion Diagnostica Oy (OD), Orion Pharma (OP), The Finnish Red Cross Blood Service (SPR) and United Medix Laboratories Ltd (YML). The research organisations: Aalto University, The Research Institute of the Finnish Economy - Etla, University of Helsinki (UH), University of Tampere (UTA), VTT Technical Research Centre of Finland. 6

7 Work Packages of Personalized Diagnostics and Care Program WP501 WP502 WP503 WP504 Infections, inflammation and enabling technologies for diagnostics and care Extracellular vesicles in health and disease Healthcare processes and electronic evidencebased decision support systems Genomics in chronic inflammation in Finland and Canada (CINFICA) Duration: Volume: 30 m Partners: 17 7

8 Responsibilities of work packages and budgeting Research Coordinator of the program since Aug 4 th 2014: Dr. Pirjo Wacklin, PhD, SalWe Oy 8

9 Infections, inflammation and enabling technologies for diagnostics and care (WP501) WP managers: Minna Mäki, Orion Diagnostica ja Harri Siitari, VTT WP501.1: Chronic inflammation and acute microbial infections in the gastrointestinal (GI) tract WP501.1A: Chronic inflammation in the GI tract WP501.1B: Acute microbial infections in the GI tract WP501.2: Diagnostics of acute respiratory tract infections WP501.2A: Novel diagnostic targets for group G and C streptocci WP501.2B: Novel diagnostic targets for viral respiratory tract infections WP501.3 Infections and inflammatory conditions during pregnancy and delivery WP501.3A: Novel diagnostic targets for early intra-amniotic infection WP501.3B: Novel diagnostic targets for Group B Streptococcus (GBS) and the GBS carrier state of the mother WP501.4: Integrated methods for sample preparation WP501.5A: One-step multiplex assay platform WP501.5B: Mobile POC technologies 9

10 Extracellular vesicles in health and disease (WP502) WP managers: Saara Laitinen, SPR Veripalvelu ja Elina Serkkola, Orion Pharma WP502.1: Extracellular vesicles in healthy donors - Blood based biomarkers WP502.2: Extracellular vesicles as a source of biomarkers for prostate cancer 10

11 Healthcare processes and electronic evidence-based decision support systems (WP 503) WP managers: Pasi Pöllänen, CAREA and Kimmo Pitkänen, HY FIMM WP503-1: Integrating Genetic Information and Electronic Clinical Decision Support WP503-2: Personalized medicine decision support system WP503-3: Immunogenetic profiling based on genome data WP503-4: Automatic decision support and supply-chain system in hospital services WP503-5: Usability, efficiency and cost-effectiveness of genomic data in the future health care: Sociological reflections WP503-6: Usability, efficiency and cost-effectiveness of genomic data in the future health care: Estimation of cost-effectiveness WP503-7a: A Business Model Perspective to Personalized Diagnostics and Care WP503-7b: Application of standardized impact and cost-benefit assessment tool in public-private partnership 11

12 Genomics in chronic inflammation in Finland and Canada (CINFICA) (WP504) WP managers: Jukka Partanen, SPR Veripalvelu and Päivi Saavalainen, HY WP504-1: Continuation of selected IMO biomarkers and platforms WP504-2: Novel genomic biomarkers WP504-3: Novel protein biomarkers WP504-4: Novel cell therapy 12

13 Goals of the program (1 ½ v) (1 ½ v) (1 v)

14 14

Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme

Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme Enablers of Intelligent Monitoring of Health and Well-being Review of the SalWe IMO - Programme Jouko Haapalahti Programme Director, SalWe Ltd Managing director, JouZeNet Consulting Ltd Coordinator, Finnish

More information

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008

HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 HealthBIO in Helsinki Region 2008 BioSA Workshops in South Africa, 31.3 2.4.2008 Riikka Paasikivi Program Director Culminatum Ltd Oy Helsinki, Finland Helsinki Region Over 1.2 million inhabitants (population

More information

Information for patients and the public and patient information about DNA / Biobanking across Europe

Information for patients and the public and patient information about DNA / Biobanking across Europe Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes

More information

BioSA Workshops in South Africa 1.-2.4.2008. Tero Piispanen, Turku Science Park Ltd

BioSA Workshops in South Africa 1.-2.4.2008. Tero Piispanen, Turku Science Park Ltd BioSA Workshops in South Africa 1.-2.4.2008 Tero Piispanen, Turku Science Park Ltd Part I - Finland FINLAND Finland facts Top Competitiveness and Creativity About 5.3 million inhabitants in 337 000 km2

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

Clinical drug trials from a university hospital's point of view. Aki Lindén, CEO, Helsinki University Hospital

Clinical drug trials from a university hospital's point of view. Aki Lindén, CEO, Helsinki University Hospital Clinical drug trials from a university hospital's point of view Aki Lindén, CEO, Helsinki University Hospital National Responsibilities and Special Areas 2014 5 university hospital districts: HUCH - Helsinki

More information

Quality and Clinical Director

Quality and Clinical Director Curriculum Vitae PERSONAL INFORMATION Minna Leppänen WORK EXPERIENCE April 2014 Present Quality and Clinical Director Scaffdex Ltd, (Finland) Responsibility in quality, regulatory and clinical issues concerning

More information

The Blood Donor BIOBANK

The Blood Donor BIOBANK The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION

More information

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER There is a range of methods available to your healthcare professional to verify the

More information

Personalized medicine in China s healthcare system

Personalized medicine in China s healthcare system Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Advanced Nursing Research in Critical Care

Advanced Nursing Research in Critical Care 12 th Congress of the World Federation of Societies of Intensive and Critical Care Medicine Advanced Nursing Research in Critical Care Yeonsoo Jang RN, PhD. Assistant Professor Yonsei University College

More information

FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO

FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO FUTURE HEALTH COOPERATION BETWEEN PUBLIC AND PRIVATE SECTORS IN KUOPIO Anneli Tuomainen, Johanna Jylhä-Ollila Kuopio Innovation Ltd, POB 4000, FI-70601 Kuopio, Finland Context In Finland, cities, companies

More information

4.11 Healthcare Technology Co-operatives Version 4 (July 2015)

4.11 Healthcare Technology Co-operatives Version 4 (July 2015) HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out

More information

IVD toimialan tuloksia, kokemuksia ja näkymiä. Results, experiences and outlook of the IVD sector

IVD toimialan tuloksia, kokemuksia ja näkymiä. Results, experiences and outlook of the IVD sector 1 IVD toimialan tuloksia, kokemuksia ja näkymiä Results, experiences and outlook of the IVD sector FinnWell Seminar of April 29, 2009 Finlandia talo, Helsinki Jouko Haapalahti,M.D,PhD.(hc), emba Assistant

More information

Our Blood Service ANNUAL REPORT

Our Blood Service ANNUAL REPORT Our Blood Service ANNUAL REPORT 2012 Finnish Red Cross Blood Service Part of the Finnish health care system THE FINNISH Red Cross Blood Service (FRCBS) is a financially and operationally independent unit

More information

Centre for Health and Technology. Maritta Perälä-Heape

Centre for Health and Technology. Maritta Perälä-Heape Centre for Health and Technology Maritta Perälä-Heape OULU INNOVATION ALLIANCE (OIA) BRINGS TOGETHER REGIONAL STAKEHOLDERS MODE OF OPERATION Systematic, contract-based co-operation between regional players

More information

Maritta Perälä-Heape

Maritta Perälä-Heape Maritta Perälä-Heape OULU INNOVATION ALLIANCE (OIA) BRINGS TOGETHER REGIONAL STAKEHOLDERS MODE OF OPERATION Systematic, contract-based RD co-operation between regional players Composing and coordinating

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

Talent Retention in the Helsinki Region: Overcoming the Language Barrier

Talent Retention in the Helsinki Region: Overcoming the Language Barrier Talent Retention in the Helsinki Region: Overcoming the Language Barrier Fluent Finnish Required For the international talents finding employment in Finland is often hindered by a lack of Finnish language

More information

ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health'

ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health' IInherriitted NeuRoMettabolliic Diiseases IINFORMATIION NETWORK ACRONIM : InNerMeD-I-Network STARTING DATE: 2013-04-01 DURATION (in months): 30 PRIORITY AREA: Actions under the second objective 'Promote

More information

60 Including some of the most influential public health thought leaders Prominent public health leaders and decision makers.

60 Including some of the most influential public health thought leaders Prominent public health leaders and decision makers. Promote & Showcase Sponsor Network & Connect About the Conference The 2nd Singapore International Public Health Conference and 11th Singapore Public Health and Occupational Medicine Conference 2016(SIPHC

More information

Horizon 2020 New Opportunities for Clinical Research in Europe

Horizon 2020 New Opportunities for Clinical Research in Europe Horizon 2020 New Opportunities for Clinical Research in Europe Ruxandra Draghia Akli, MD, PhD Director, Health Research DG Research and Innovation European Commission Electronic Health Records for Clinical

More information

A leader in the development and application of information technology to prevent and treat disease.

A leader in the development and application of information technology to prevent and treat disease. A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today

More information

The National Centre for Biomedical Engineering Science

The National Centre for Biomedical Engineering Science The How this Integrated Technology Platform has impacted the development of R&D Clusters in Galway Jacinta Thornton, PhD Executive Manager, NCBES National Centre for Biomedical Engineering g Science Mission

More information

Helsinki Business Hub. 23 September 2009, Eero Holstila

Helsinki Business Hub. 23 September 2009, Eero Holstila Helsinki Business Hub 2009 23 September 2009, Eero Holstila testi Strategic location Helsinki Performs 2nd/ 118 European Competitiveness Index 2006-2007 6th/ 131 Global Competitiveness Index 2008-2009

More information

Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank

Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank Blood Biobanking Chances and Risks The Bavarian Red Cross Blood Donor Biobank EORTC-NCI-ASCO Meeting - November 2007 Outline Types of biobanking Why blood biobanking? Why blood banks? Why the Bavarian

More information

David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing»

David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing» David ITIER Coordinator of European Affairs at Institut Pasteur National Contact Point «Health, demographic change and Wellbeing» Chisinau, 9th November 2015 1 Key features on Horizon 2020 Chisinau, 9th

More information

Education Program Curriculum

Education Program Curriculum Academy of Life Underwriting Education Program Curriculum ALU CURRICULUM The ALU curriculum offers study materials and a series of ALU exams which allow a student to gain a broad understanding of the requirements

More information

Health and Social Care Level 3. Unit 6 Sociological perspectives for health and social care

Health and Social Care Level 3. Unit 6 Sociological perspectives for health and social care Unit 6 Sociological perspectives for health and social care Definitions of Health Instructions and answers for Teachers These instructions should accompany the OCR resource Definitions of Health, which

More information

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis We are MyCartis Let s make healthcare personal The big revolution in healthcare today is that we are finally realizing

More information

How can we generate economic value from personalized medicine and big data analysis?

How can we generate economic value from personalized medicine and big data analysis? Estonian Health Innovation Forum 2015 Focus on Personalised Medicine How can we generate economic value from personalized medicine and big data analysis? Jonathan Knowles October 26, 2015 Tallinn, Viru

More information

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health

More information

THE LINCOLN INSTITUTE OF HEALTH

THE LINCOLN INSTITUTE OF HEALTH THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges

More information

Information Technology in Healthcare

Information Technology in Healthcare Project name Seminar Report Information Technology in Healthcare Authors Thirza van den Broek Venla Virkamäki On Tuesday May 19, 2015, the Embassy of the Kingdom of the Netherlands together with Philips

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology

More information

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015

MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015 19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All

More information

In Vitro Diagnostics

In Vitro Diagnostics REVIEW 316/2015 In Vitro Diagnostics a Finnish Success Story A Review of the Finnish IVD Industry Development and Their Success in the Global Market Dr Paul Mundill Tekes the Finnish Funding Agency for

More information

JAMK University of Applied Sciences. School of Health and Social Studies

JAMK University of Applied Sciences. School of Health and Social Studies JAMK University of Applied Sciences School of Health and Social Studies We promote competence in health and well-being. Ph.D. Pertti Malkki, Director, JAMK, School of Health and Social Studies 1650 Students

More information

From the Dean. Tuija Pulkkinen Dean

From the Dean. Tuija Pulkkinen Dean Signal of quality From the Dean At the School of Electrical Engineering, science and engineering meet society. Our portfolio covers fields from natural sciences to engineering and information sciences.

More information

Breast cancer and genetics

Breast cancer and genetics Breast cancer and genetics Cancer and genes Our bodies are made up of millions of cells. Each cell contains a complete set of genes. We have thousands of genes. We each inherit two copies of most genes,

More information

FIMECC Ltd. 15.6.2010

FIMECC Ltd. 15.6.2010 FIMECC Ltd. FIMECC Ltd. is private owned company that coordinates company driven research programs in the field of mechanical engineering and metals The platform that FIMECC implements is a national publicprivate

More information

MASTER S DEGREE PROGRAMME IN BIOINFORMATICS

MASTER S DEGREE PROGRAMME IN BIOINFORMATICS 07.07.08.mat.luonnont.sivut 08 7.7.2008 13:44 Sivu 183 MASTER S DEGREE PROGRAMME IN BIOINFORMATICS Department of Computer Science Department of Mathematics and Statistics Exactum (Kumpula Campus) PO Box

More information

Nanomedicine in Horizon 2020

Nanomedicine in Horizon 2020 Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies heico.frima@ec.europa.eu ETPN Annual Event 2014

More information

Innovate to accelerate

Innovate to accelerate Innovate to accelerate Turku Science Park - focused business development and a campus area Two universities: University of Turku and Åbo Akademi University Turku University of Applied Sciences, Diaconia

More information

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

UMEÅ INTERNATIONAL SCHOOL

UMEÅ INTERNATIONAL SCHOOL UMEÅ INTERNATIONAL SCHOOL OF PUBLIC HEALTH Master Programme in Public Health - Programme and Courses Academic year 2015-2016 Public Health and Clinical Medicine Umeå International School of Public Health

More information

Toward Acceleration of Open Innovation

Toward Acceleration of Open Innovation Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New

More information

VTT as an Innovation Partner. Petri Kalliokoski EVP, Strategy and Business Development

VTT as an Innovation Partner. Petri Kalliokoski EVP, Strategy and Business Development VTT as an Innovation Partner Petri Kalliokoski EVP, Strategy and Business Development 2 Agenda 18.1.2012 9:00 Welcome, VTT as an Innovation Partner/Petri Kalliokoski, Executive Vice President 9:30 Experiences

More information

Guide to Understanding Breast Cancer

Guide to Understanding Breast Cancer An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients

More information

Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org

Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org Selective IgA deficiency (slgad) hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on selective IgA deficiency (sigad). It has been produced by the PID UK

More information

Groundbreaking Collaborative Clinical Trial Launched

Groundbreaking Collaborative Clinical Trial Launched Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)

More information

CLEEN - The vehicle for SGEM

CLEEN - The vehicle for SGEM CLEEN - The vehicle for SGEM Centre for Strategic Science, Technology and Innovation (CSTI) Co-operative and Industry Driven R&D&I company for Energy and Environment founded in 2008. Unique in it s way

More information

Understanding specialty drugs

Understanding specialty drugs Group Benefits Understanding specialty drugs What your pharmaceutical benefits plan may look like over the next decade Between 2011 and 2014, the percentage of total drug spend represented by specialty

More information

Dr Paul Mundill Innostics Innostics Oy

Dr Paul Mundill Innostics Innostics Oy Dr Paul Mundill Innostics Oy Future Diagnostics Finland Ideas for Query 2009 The aim was to assess the future directions and needs of the Finnish in vitro diagnostics industry and to collect foresights

More information

Ylilääkäri/osa-aikainen (35 %) professori 24.1.2014. Opetuskokemus

Ylilääkäri/osa-aikainen (35 %) professori 24.1.2014. Opetuskokemus HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN SATU 8.5.2014 LIITE 2 HUS-Kuvantaminen Kliinisen fysiologian ja isotooppilääketieteen vastuualue Ylilääkäri/osa-aikainen (35 %) professori 24.1.2014 Hakija Tutkinnot

More information

Figure 14.2 Overview of Innate and Adaptive Immunity

Figure 14.2 Overview of Innate and Adaptive Immunity I M M U N I T Y Innate (inborn) Immunity does not distinguish one pathogen from another Figure 14.2 Overview of Innate and Adaptive Immunity Our first line of defense includes physical and chemical barriers

More information

INNOVATIONS. Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere

INNOVATIONS. Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere INNOVATIONS FOR WELLBEING Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere 1 BioneXt BioneXt Tampere was a development and investment programme focusing on top- level research, product development,

More information

Corportate Wellness Programs

Corportate Wellness Programs Corportate Wellness Programs EAST WEST HEALTH CORPORATE WELLNESS PROGRAMS WE SAVE LIVES BY MOTIVATING INDIVIDUALS AND ORGANIZATIONS TO GET AND STAY HEALTHY. What s going on with the health of our country?

More information

Genetic diagnostics the gateway to personalized medicine

Genetic diagnostics the gateway to personalized medicine Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed

More information

LIFE SCIENCE GROUP LSG Health is a group effort

LIFE SCIENCE GROUP LSG Health is a group effort LIFE SCIENCE GROUP LSG Health is a group effort BASIC INFORMATION AND COMMUNICATION PLAN + Q&A 1. BASIC INFORMATION Project Life Science Group Stakeholders Advisory group Pharma Health Tech Industry associations,

More information

XIV ANNUAL MEETING OF NURSING

XIV ANNUAL MEETING OF NURSING Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I

More information

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Clinical trials: The EU perspective Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Content 1.EU: The global picture 2.EU & Clinial trials: The

More information

Global Wellness Technology Business. High Potential for Future Success. Pasi Sorvisto 25.11.2005

Global Wellness Technology Business. High Potential for Future Success. Pasi Sorvisto 25.11.2005 Global Wellness Technology Business High Potential for Future Success Pasi Sorvisto 25.11.2005 What kind of Business we are talking about? Spending on healthcare in U.S. is 14% and in Europe 8,5% of GDP.

More information

Gene Therapy and Genetic Counseling. Chapter 20

Gene Therapy and Genetic Counseling. Chapter 20 Gene Therapy and Genetic Counseling Chapter 20 What is Gene Therapy? Treating a disease by replacing, manipulating or supplementing a gene The act of changing an individual s DNA sequence to fix a non-functional

More information

BIOSCIENCES COURSE TITLE AWARD

BIOSCIENCES COURSE TITLE AWARD COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,

More information

Guidelines for health professionals about DNA / Biobanking in Europe

Guidelines for health professionals about DNA / Biobanking in Europe Guidelines for health professionals about DNA / Biobanking in Europe BIOBANKING SUMMARY A "biobank" is a: "service unit, non-profit organization for the collection and preservation of biological material

More information

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes

More information

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. 11111 This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. In summary Genes contain the instructions for

More information

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...

More information

At-a-glance unit content, assessment criteria and guidance

At-a-glance unit content, assessment criteria and guidance At-a-glance unit content, assessment criteria and guidance To help you with assignment writing as well as assessing assignments, this table maps the Unit 7 content against the Unit 7 assessment criteria

More information

Medicare Coverage of Genomic Testing

Medicare Coverage of Genomic Testing Medicare Coverage of Genomic Testing Louis B. Jacques, MD Director, DID/CAG/OCSQ With acknowledgements to Jeff Roche, MD Social Security Act 1862(a)(1)(A) Notwithstanding any other provision of this title,

More information

m Computational Biology (CB) Wellness and heal Ophthalmic medicines a als and implants for mending bones Biodegr

m Computational Biology (CB) Wellness and heal Ophthalmic medicines a als and implants for mending bones Biodegr and devices Implants and devices for surg m Computational Biology (CB) Wellness and heal Ophthalmic medicines a als and implants for mending bones Biodegr and devices for surgery Sensor and measurement

More information

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything

P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything P4 Medicine: Personalized, Predictive, Preventive, Participatory A Change of View that Changes Everything Leroy E. Hood Institute for Systems Biology David J. Galas Battelle Memorial Institute Version

More information

english facts about hepatitis A, B and C

english facts about hepatitis A, B and C english facts about hepatitis A, B and C What is hepatitis? Hepatitis means inflammation of the liver. Many viruses can cause liver inflammation, including the hepatitis A, B and C viruses. Some people

More information

Medical Therapies Limited EGM Presentation

Medical Therapies Limited EGM Presentation Medical Therapies Limited EGM Presentation Maria Halasz Chief Executive Officer 5 May 2009 1 Agenda 1. Company information 2. Recent developments 3. Business strategy 4. Key value inflection points for

More information

Briefing on ehr Content Hong Kong Clinical Terminology Table (HKCTT) By Maggie LAU Health Informatician, ehriso

Briefing on ehr Content Hong Kong Clinical Terminology Table (HKCTT) By Maggie LAU Health Informatician, ehriso Briefing on ehr Content Hong Kong Clinical Terminology Table (HKCTT) By Maggie LAU Health Informatician, ehriso Agenda Background Application Adoption Management RecognisedTerminologies in ehr Registered

More information

Increase Hepatitis C Virus Screening and Treatment

Increase Hepatitis C Virus Screening and Treatment 18 Increase Hepatitis C Virus Screening and Treatment Situation The number of deaths from liver cancer in Japan has been rising rapidly since 1975, and now stands at more than 30,000 per year. About 80

More information

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care

Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Submission by the Irish Pharmacy Union to the Department of Health on the Scope for Private Health Insurance to incorporate Additional Primary Care Services January 2015 1 IPU Submission to the Department

More information

QUESTIONS FOR The Commonwealth Medical College

QUESTIONS FOR The Commonwealth Medical College Page 1 QUESTIONS FOR The Commonwealth Medical College PROCESS OF CURRICULUM REDESIGN Why did you redesign your curriculum? What were your goals? What was the timeframe? What lessons were learned while

More information

Finnish Society of Telemedicine and ehealth

Finnish Society of Telemedicine and ehealth Finnish Society of Telemedicine and ehealth Finnish Society of Telemedicine and ehealth is an important forerunner in We have a close collaboration with other national and international organisations,

More information

NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES

NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES PRESS RELEASE NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES European research centres in life sciences gather to foster excellence in research, share knowledge, and influence

More information

Human Health Sciences

Human Health Sciences Human Health Sciences WITH PLYMOUTH UNIVERSITY DISCOVER MORE If you would like to visit Plymouth and meet our staff, then why not come along to one of our open days. Human Health Sciences WITH PLYMOUTH

More information

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri)

ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following:

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following: Cystic Fibrosis What is cystic fibrosis? Cystic fibrosis (CF) is an inherited disease characterized by an abnormality in the glands that produce sweat and mucus. It is chronic, progressive, and is usually

More information

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing These Are Hopeful Times for Lung Cancer Survivors When people first learn they have cancer, they are often afraid. But

More information

Degree. Typical Tasks for Graduates. Implementation of Studies. CURRICULUM NURSING Centre for Social Services and Health Care

Degree. Typical Tasks for Graduates. Implementation of Studies. CURRICULUM NURSING Centre for Social Services and Health Care CURRICULUM NURSING Centre for Social Services and Health Care At Karelia University of Applied Sciences you will complete your Bachelor of Health Care Degree in a multidisciplinary and modern learning

More information

Answering your questions on Chronic Myeloid Leukaemia (CML)

Answering your questions on Chronic Myeloid Leukaemia (CML) Answering your questions on Chronic Myeloid Leukaemia (CML) Your guide to understanding CML and Glivec (imatinib) treatment The information in this booklet is designed to help you understand chronic myeloid

More information

How does genetic testing work?

How does genetic testing work? How does genetic testing work? What is a genetic test? A genetic test looks at to find changes (variants) that cause disease or put you at greater risk to develop disease. DNA is the code our bodies use

More information

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex

More information

A. Sue Carlisle, PhD, MD Professor of Anesthesia and Medicine Associate Dean for UCSF at SFGH

A. Sue Carlisle, PhD, MD Professor of Anesthesia and Medicine Associate Dean for UCSF at SFGH A. Sue Carlisle, PhD, MD Professor of Anesthesia and Medicine Associate Dean for UCSF at SFGH VIEW FROM 23RD STREET 10 10 100,000 individuals seen/year 600,000 outpatient visits 16,500 admissions 6000

More information

KYAMK Grow strong. KYAMK. internationally connected reliable partner. kyamk.fi

KYAMK Grow strong. KYAMK. internationally connected reliable partner. kyamk.fi KYAMK internationally connected reliable partner kyamk.fi 1 GROW STRONG. KYAMK IN BRIEF (figures approximate) 4,300 students 1,000 new students each year 330 members of staff, of whom 175 are teachers

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

SMF Awareness Seminar 2014

SMF Awareness Seminar 2014 SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

Health Data Governance: Privacy, Monitoring and Research - Policy Brief

Health Data Governance: Privacy, Monitoring and Research - Policy Brief Health Data Governance: Privacy, Monitoring and Research - Policy Brief October 2015 www.oecd.org/health Highlights All countries can improve their health information systems and make better use of data

More information